SMITH JASON DREW (General Counsel) sold 11.9% of their position (7.48K shares) of UROGEN PHARMA LTD. on the open market

Open‑market sale worth $147.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales

SMITH JASON DREW

Filed: 2/11/2026ACC: 0001437749-26-003778

InsiderSMITH JASON DREWCIK 1821479

→

IssuerUROGEN PHARMA LTD.CIK 1668243

Officer· General Counsel

Since Aug 2020

+25.13K

Net shares

Net buyer

$147.3K

Total sold

Open market trades

0B · 3S

Total transactions

48.11K acquired · 22.98K disposed

Non-Derivative Transactions6

Ordinary Shares

Direct

M · Option Exercise

+5.50K

Price / share

—

Trade value

—

% of position

11.0%

1/31/2026

49.97K→55.47K

Ordinary Shares

Direct

M · Option Exercise

+3.33K

Price / share

—

Trade value

—

% of position

6.0%

1/31/2026

55.47K→58.80K

Ordinary Shares

Direct

M · Option Exercise

+6.67K

Price / share

—

Trade value

—

% of position

15.4%

1/31/2026

43.30K→49.97K

Ordinary Shares

Direct

S · Sale

−2.65K

Price / share

$19.69

Trade value

$52.26K

% of position

4.8%

2/3/2026

55.59K→52.93K

Ordinary Shares

Direct

S · Sale

−1.61K

Price / share

$19.69

Trade value

$31.66K

% of position

3.0%

2/3/2026

52.93K→51.33K

Ordinary Shares

Direct

S · Sale

−3.22K

Price / share

$19.69

Trade value

$63.34K

% of position

5.5%

2/3/2026

58.80K→55.59K

Total

Net shares

+8.02K

Net value

-$147.26K

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Ordinary Shares Direct	1/31/2026	M · Option Exercise	+5.50K	—	—	11.0%	49.97K	55.47K
Ordinary Shares Direct	1/31/2026	M · Option Exercise	+3.33K	—	—	6.0%	55.47K	58.80K
Ordinary Shares Direct	1/31/2026	M · Option Exercise	+6.67K	—	—	15.4%	43.30K	49.97K
Ordinary Shares Direct	2/3/2026	S · Sale	−2.65K	$19.69	$52.26K	4.8%	55.59K	52.93K
Ordinary Shares Direct	2/3/2026	S · Sale	−1.61K	$19.69	$31.66K	3.0%	52.93K	51.33K
Ordinary Shares Direct	2/3/2026	S · Sale	−3.22K	$19.69	$63.34K	5.5%	58.80K	55.59K
Total			+8.02K		-$147.26K

Derivative Transactions4

Restricted Stock Units

Direct

M · Option Exercise

Converts to

Ordinary Shares

5.50K shares

−5.50K

Strike price

Held after

5.50K

Exercisable

—

1/31/2026

Restricted Stock Units

Direct

M · Option Exercise

Converts to

Ordinary Shares

3.33K shares

−3.33K

Strike price

Held after

6.67K

Exercisable

—

1/31/2026

Restricted Stock Units

Direct

M · Option Exercise

Converts to

Ordinary Shares

6.67K shares

−6.67K

Strike price

Held after

0.00

Exercisable

—

1/31/2026

Restricted Stock Units

Direct

A · Award

Converts to

Ordinary Shares

32.61K shares

+32.61K

Strike price

Held after

32.61K

Exercisable

—

1/31/2026

Security	Converts To	Date	Type	Shares	Exercisable	Held After
Restricted Stock Units Direct	Ordinary Shares5.50K shares	1/31/2026	M · Option Exercise	−5.50K	—	5.50K
Restricted Stock Units Direct	Ordinary Shares3.33K shares	1/31/2026	M · Option Exercise	−3.33K	—	6.67K
Restricted Stock Units Direct	Ordinary Shares6.67K shares	1/31/2026	M · Option Exercise	−6.67K	—	0.00
Restricted Stock Units Direct	Ordinary Shares32.61K shares	1/31/2026	A · Award	+32.61K	—	32.61K